Treatment of patients with chronic lymphocytic leukemia with 17p deletion: the saga continues

Leuk Lymphoma. 2012 Feb;53(2):179-80. doi: 10.3109/10428194.2011.638719. Epub 2011 Dec 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Oligonucleotides / therapeutic use*
  • Tumor Suppressor Protein p53 / antagonists & inhibitors*

Substances

  • Oligonucleotides
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • cenersen